The Mumbai-based Jyothy Laboratories, which last week acquired a 14.9% stake in Henkel India, is looking to aggressively turnaround the business if it triumphs in its bid for parent Henkel AG's 50.97% in the Indian unit.
Jyothy Laboratories's Vice-Chairman Ulhas Kamath said the firm was looking to turn Henkel profitable in a year or two. 'It has to happen as quickly as possible. For that we will use every lever possible from manufacturing to distribution to brand-building,' he said.Mr Kamath admitted that Jyothy Laboratories would have to invest substantially in the first year to revive the health of the business, something that has made investors jittery since the 14.9% acquisition last week.
Jyothy Laboratories's Vice-Chairman Ulhas Kamath said the firm was looking to turn Henkel profitable in a year or two. 'It has to happen as quickly as possible. For that we will use every lever possible from manufacturing to distribution to brand-building,' he said.Mr Kamath admitted that Jyothy Laboratories would have to invest substantially in the first year to revive the health of the business, something that has made investors jittery since the 14.9% acquisition last week.
